Thrombolysis Indications and Management in STEMI
Thrombolytic therapy is indicated in all STEMI patients with symptoms of ischemia less than 12 hours duration and persistent ST-segment elevation when primary PCI cannot be performed in a timely manner (within 120 minutes of first medical contact). 1
Primary Indications for Thrombolysis in STEMI
- First-line indication: When primary PCI cannot be performed within 120 minutes after STEMI diagnosis 1
- Time window: Within 12 hours of symptom onset in patients without contraindications 1
- ECG criteria: Persistent ST-segment elevation or new-onset left bundle branch block 1
- Administration timing: Should be initiated as soon as possible after STEMI diagnosis, preferably in the pre-hospital setting 1
Contraindications to Thrombolysis
Thrombolytic therapy is contraindicated in patients with:
- Active internal bleeding
- History of cerebrovascular accident
- Intracranial or intraspinal surgery or trauma within 2 months
- Intracranial neoplasm, arteriovenous malformation, or aneurysm
- Known bleeding diathesis
- Severe uncontrolled hypertension 2
Thrombolytic Agent Selection and Administration
- Preferred agents: Fibrin-specific agents (tenecteplase, alteplase, or reteplase) 1
- Tenecteplase dosing: Individualized based on patient's weight, administered as a single bolus over 5 seconds 2
- Administration route: Intravenous only 2
Adjunctive Antithrombotic Therapy with Thrombolysis
Antiplatelet therapy:
Anticoagulation:
Post-Thrombolysis Management
Transfer strategy:
Rescue PCI indications:
Special Considerations for Timing
- Early presenters (within 2 hours of symptom onset) may have particular benefit from thrombolysis compared to delayed primary PCI 4
- For patients <75 years with large anterior infarction presenting within 2 hours of symptom onset, primary PCI should be performed within 90 minutes of first medical contact 3
- If primary PCI cannot be performed within the recommended timeframe, thrombolysis should be initiated within 30 minutes of first medical contact 5
Post-Reperfusion Care
- Echocardiography during hospital stay to assess LV and RV function, detect mechanical complications, and exclude LV thrombus 1
- Cardiac rehabilitation program participation is recommended 1
- Smoking cessation support with nicotine replacement therapies, varenicline, and bupropion 1
Monitoring for Complications
- Bleeding: Avoid intramuscular injections and nonessential handling of the patient for the first few hours following treatment 2
- Arrhythmias: Have anti-arrhythmic therapy available for bradycardia and/or ventricular irritability 2
- Hypersensitivity: Monitor patients during and for several hours after infusion 2
- Cholesterol embolism: Has been reported with thrombolytic agents 2
Key Pitfalls to Avoid
- Delayed administration: Thrombolytic efficacy decreases with time; administer as soon as possible after STEMI diagnosis
- Inappropriate patient selection: Carefully screen for contraindications to minimize bleeding risk
- Failure to transfer: All patients should be transferred to a PCI-capable center after thrombolysis
- Missing failed thrombolysis: Monitor for signs of reperfusion failure and perform rescue PCI when indicated
- Inadequate anticoagulation: Ensure proper anticoagulation is maintained after thrombolysis
The evidence strongly supports a reperfusion strategy that prioritizes timely treatment. While primary PCI is the preferred method when available within the recommended timeframe, thrombolysis remains a critical intervention when timely PCI is not feasible, with subsequent transfer to a PCI-capable facility for potential early intervention.